These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 19588357)
21. Thrombolysis versus anticoagulation for the initial treatment of moderate pulmonary embolism: a meta-analysis of randomized controlled trials. Chen H; Ren C; Chen H Respir Care; 2014 Dec; 59(12):1880-7. PubMed ID: 25269681 [TBL] [Abstract][Full Text] [Related]
22. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism. Robertson L; Strachan J Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640 [TBL] [Abstract][Full Text] [Related]
23. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. Chatterjee S; Chakraborty A; Weinberg I; Kadakia M; Wilensky RL; Sardar P; Kumbhani DJ; Mukherjee D; Jaff MR; Giri J JAMA; 2014 Jun; 311(23):2414-21. PubMed ID: 24938564 [TBL] [Abstract][Full Text] [Related]
24. Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis. Zhang Z; Zhai ZG; Liang LR; Liu FF; Yang YH; Wang C Thromb Res; 2014 Mar; 133(3):357-63. PubMed ID: 24412030 [TBL] [Abstract][Full Text] [Related]
25. Current Controversies in Thrombolytic Use in Acute Pulmonary Embolism. Long B; Koyfman A J Emerg Med; 2016 Jul; 51(1):37-44. PubMed ID: 27071316 [TBL] [Abstract][Full Text] [Related]
26. Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke. Liu M; Wardlaw J Cochrane Database Syst Rev; 2000; (2):CD000514. PubMed ID: 10796381 [TBL] [Abstract][Full Text] [Related]
28. Systemic Thrombolytic Therapy for Massive and Submassive Pulmonary Embolism. Igneri LA; Hammer JM J Pharm Pract; 2020 Feb; 33(1):74-89. PubMed ID: 29673293 [TBL] [Abstract][Full Text] [Related]
29. Short term effect of recombinant tissue plasminogen activator in patients with hemodynamically stable acute pulmonary embolism: results of a meta-analysis involving 464 patients. Tardy B; Venet C; Zeni F; Coudrot M; Guyomarc'h S; Mismetti P Thromb Res; 2009 Dec; 124(6):672-7. PubMed ID: 19493561 [TBL] [Abstract][Full Text] [Related]
30. Should thrombolytic therapy be used in patients with pulmonary embolism? Konstantinides S Am J Cardiovasc Drugs; 2004; 4(2):69-74. PubMed ID: 15049719 [TBL] [Abstract][Full Text] [Related]
31. Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis. Agnelli G; Becattini C; Kirschstein T Arch Intern Med; 2002 Dec 9-23; 162(22):2537-41. PubMed ID: 12456225 [TBL] [Abstract][Full Text] [Related]
32. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Goldhaber SZ; Haire WD; Feldstein ML; Miller M; Toltzis R; Smith JL; Taveira da Silva AM; Come PC; Lee RT; Parker JA Lancet; 1993 Feb; 341(8844):507-11. PubMed ID: 8094768 [TBL] [Abstract][Full Text] [Related]